| P50 | author | James Douketis | Q100404477 |
| P2093 | author name string | Benjamin R Bell | |
| | Pascal E Bastien | |
| | Thrombosis Canada | |
| P2860 | cites work | Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632872 |
| | Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632902 |
| | Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 |
| | A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis | Q30441687 |
| | Clinical practice. Heparin-induced thrombocytopenia | Q33372371 |
| | Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series | Q33396967 |
| | Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial | Q34343613 |
| | Aspirin in patients undergoing noncardiac surgery | Q34412633 |
| | Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery | Q34561015 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial | Q34607209 |
| | Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? | Q34714374 |
| | Prevention of venous thromboembolism in obesity | Q35633708 |
| | Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752584 |
| | Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. | Q37796578 |
| | Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). | Q43201516 |
| | Apixaban or enoxaparin for thromboprophylaxis | Q43239246 |
| | Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials | Q43250059 |
| | Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH. | Q43847029 |
| | Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. | Q43856527 |
| | Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery | Q43856529 |
| | New pharmacologic methods to prevent venous thromboembolism in older adults: a meta-analysis | Q44005849 |
| | Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison | Q44017888 |
| | Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. | Q44017891 |
| | Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement | Q44630656 |
| | Rivaroxaban for thromboprophylaxis | Q46246369 |
| | Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial | Q47231387 |
| | The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. | Q53229008 |
| | Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. | Q55044458 |
| | Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. | Q55044630 |
| | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial | Q57943255 |
| P433 | issue | 2 | |
| P921 | main subject | venous thromboembolism | Q9397786 |
| P304 | page(s) | 194-202 | |
| P577 | publication date | 2014-11-13 | |
| P1433 | published in | Canadian Journal of Anaesthesia | Q2511577 |
| P1476 | title | Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review | |
| P478 | volume | 62 | |